Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, August 20, 2026. 12 PM-1:30 PM ET
Hear from an expert in HER2 IHC whose work has contributed to current scoring guidelines.

Webinar presenter Josef Ruschoff, MD, PhD, Former Chief Medical Officer and Co-Founder of Targos, Senior Consultant of Discovery Life Sciences, Kassel, Germany.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

To be rescheduled to a future date
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.

Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace Directory

FDA clears Sysmex CN-6000 automated blood coag analyzer

July 2025—Sysmex America has received FDA clearance for its CN-6000 automated blood coagulation analyzer. The clearance also covers reagent products for prothrombin time seconds and PT INR (Dade Innovin), activated partial thromboplastin time (Dade Actin FSL), fibrinogen (Dade thrombin reagent), antithrombin (Innovance antithrombin), and D-dimer (Innovance D-dimer). Sysmex has also received Health Canada license for the CN-6000 as well as its CN-3000 automated blood coagulation analyzer.

Empire Genomics, BioDot to launch hematology FISH probe panels

July 2025—Empire Genomics and BioDot have partnered to launch a line of hematology-focused FISH probe panels and controls. The BDot Probe line is preoptimized, ready to use, and validated for performance on the BioDot CellWriter S platform. The initial release of the panels includes targeted solutions for FISH analysis of a range of hematologic malignancies, including multiple myeloma, myelodysplastic syndromes, chronic myelogenous leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, and other common hematologic disorders.

Pillar raises $34.5 million in funding

July 2025—Pillar Biosciences announced it has finalized $34.5 million in funding, which includes a strategic investment from Illumina and structured financing from Soleus Capital, as well as investments from existing investors. The proceeds will be leveraged to advance commercial activities, including infrastructure to support biopharma partnerships, and expand adoption of its distributable clinical testing kits.

Agilent unveils InfinityLab Pro iQ series

July 2025—Agilent Technologies has launched its Agilent InfinityLab Pro iQ series of mass detectors for liquid chromatography. The series includes the InfinityLab Pro iQ and InfinityLab Pro iQ Plus and supports applications such as mass confirmation, impurity profiling, biomolecule characterization, trace contaminant detection, and compound purification. The Pro iQ system, with a mass range of m/z 2–1,600, is optimized for small molecule analysis, while the Pro iQ Plus system is engineered for high-end applications and has a mass range of m/z 2–3,000.

Qiagen plans launch of three sample prep instruments

July 2025—Qiagen plans to launch three sample preparation instruments this year and next to expand its portfolio for automated sample preparation. QIAsymphony Connect, the next generation of the QIAsymphony, is progressing toward a phased launch to selected customers this year. The system, for in vitro diagnostic use, addresses pathogen nucleic acid extraction and other applications and can process up to 96 samples at a time. It features improved automation capabilities for sample tracking and new applications, higher yield for increase in assay sensitivity, and digital connectivity.

Labcorp launches MRD, liquid biopsy solutions

July 2025—Labcorp has expanded its precision oncology portfolio with its Labcorp Plasma Detect, to help assess the risk of disease recurrence in stage three colon cancer patients, and PGDx Elio Plasma Focus Dx, a kitted, pan-solid tumor liquid biopsy test authorized by the FDA to identify patients who may benefit from targeted treatments.

ARUP launches pTau 217 blood test

July 2025—ARUP Laboratories now provides a blood test for phosphorylated tau 217 to assist in identifying whether symptoms of cognitive decline in patients ages 60 years and older are related to Alzheimer’s disease pathology.

BD gets FDA 510(k) clearance for advanced microbiology solution

July 2025—BD announced FDA 510(k) clearance for the BD Phoenix M50 automated microbiology solution and BDXpert system on the BD Synapsys informatics solution, leveraging rapid identification and antimicrobial susceptibility testing algorithms to assist in interpreting complex diagnostic data to help ensure accurate and reliable diagnoses related to antimicrobial resistance. BDXpert is an automated, rule-based system that analyzes ID and AST results from the BD Phoenix M50 system.

Techcyte launches wet mount iodine solution

July 2025—Techcyte announced the launch of its wet mount iodine solution for research use only in the United States. The AI-assisted screening tool is designed to help users locate, count, and preclassify parasites from iodine-stained fecal slides. The solution is part of Techcyte’s Fusion parasitology suite, which includes the company’s trichrome and modified acid fast solutions.

BioMérieux acquires Day Zero Diagnostics

July 2025—BioMérieux has agreed to acquire Day Zero Diagnostics, an infectious disease diagnostics company, with the aim of enhancing BioMérieux’s capabilities in next-generation sequencing and rapid diagnostics. Day Zero Diagnostics, based in Watertown, Mass., has developed technologies that integrate direct from whole blood sample preparation, sequencing, and advanced infectious disease and antimicrobial susceptibility testing analytics. The sequencing-based rapid diagnostic in development can identify the species and antibiotic resistance profile of a bacterial pathogen within hours.

MARKETPLACE

TRENDING